These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 33780416)

  • 41. An early prevention of hypoxemia in COVID-19 patients complaining obstructive sleep apnea.
    Machado C; Brock B; Machado Y; Chinchilla M
    Sleep Med; 2021 Sep; 85():322. PubMed ID: 34154934
    [No Abstract]   [Full Text] [Related]  

  • 42. Pulmonary Vascular Changes in Acute Respiratory Distress Syndrome due to COVID-19.
    Jha AK
    Am J Respir Crit Care Med; 2021 Jan; 203(2):259-260. PubMed ID: 33085907
    [No Abstract]   [Full Text] [Related]  

  • 43. Authors' response: metabolic and drug-based approach of obstructive sleep apnea (OSA) patients with COVID-19.
    Hariyanto TI; Kurniawan A
    Sleep Med; 2021 Sep; 85():321. PubMed ID: 34229966
    [No Abstract]   [Full Text] [Related]  

  • 44. Prone positioning in intubated and mechanically ventilated patients with SARS-CoV-2.
    Chen Y; Zhang J; Feng H; Wan F; Zhang Y; Tan L
    J Clin Anesth; 2021 Aug; 71():110258. PubMed ID: 33812212
    [No Abstract]   [Full Text] [Related]  

  • 45. Acute Respiratory Distress Syndrome Treated With Awake Extracorporeal Membrane Oxygenation in a Patient With COVID-19 Pneumonia.
    Li T; Yin PF; Li A; Shen MR; Yao YX
    J Cardiothorac Vasc Anesth; 2021 Aug; 35(8):2467-2470. PubMed ID: 33262038
    [No Abstract]   [Full Text] [Related]  

  • 46. Thyroid complications of SARS and coronavirus disease 2019 (COVID-19).
    Speer G; Somogyi P
    Endocr J; 2021 Feb; 68(2):129-136. PubMed ID: 33473054
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heterogeneity of Acute Respiratory Distress Syndrome in COVID-19: "Typical" or Not?
    Maley JH; Winkler T; Hardin CC
    Am J Respir Crit Care Med; 2020 Aug; 202(4):618-619. PubMed ID: 32579019
    [No Abstract]   [Full Text] [Related]  

  • 48. [Corticosteroids treatment for COVID-19].
    Salinas M
    Rev Med Chil; 2020 Jul; 148(7):893-894. PubMed ID: 33399672
    [No Abstract]   [Full Text] [Related]  

  • 49. COVID-19-related Acute Respiratory Distress Syndrome: Not So Atypical.
    Bos LDJ
    Am J Respir Crit Care Med; 2020 Aug; 202(4):622-624. PubMed ID: 32579026
    [No Abstract]   [Full Text] [Related]  

  • 50. Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter's and Gitelman's syndrome patients.
    Calò LA; Bertoldi G; Davis PA
    Pharmacol Res; 2020 Aug; 158():104903. PubMed ID: 32430287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reply to: 'The hyperdynamic circulatory profile of patients with COVID-19-related acute vascular distress syndrome'.
    Caravita S; Senni M; Parati G
    Eur J Heart Fail; 2021 Mar; 23(3):493-494. PubMed ID: 33480144
    [No Abstract]   [Full Text] [Related]  

  • 52. Management of COVID-19 Respiratory Distress.
    Marini JJ; Gattinoni L
    JAMA; 2020 Jun; 323(22):2329-2330. PubMed ID: 32329799
    [No Abstract]   [Full Text] [Related]  

  • 53. Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay.
    Galassi G; Marchioni A
    Acta Neurol Belg; 2021 Jun; 121(3):633-642. PubMed ID: 33811309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Haemodynamic impact of positive end-expiratory pressure in SARS-CoV-2 acute respiratory distress syndrome: oxygenation versus oxygen delivery.
    Barthélémy R; Beaucoté V; Bordier R; Collet M; Le Gall A; Hong A; de Roquetaillade C; Gayat E; Mebazaa A; Chousterman BG
    Br J Anaesth; 2021 Feb; 126(2):e70-e72. PubMed ID: 33223045
    [No Abstract]   [Full Text] [Related]  

  • 55. Treatment for severe acute respiratory distress syndrome from COVID-19.
    Matthay MA; Aldrich JM; Gotts JE
    Lancet Respir Med; 2020 May; 8(5):433-434. PubMed ID: 32203709
    [No Abstract]   [Full Text] [Related]  

  • 56. Respiratory and ventilator management of COVID-19.
    Khan NA; Akhtar J
    J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S60-S63. PubMed ID: 32515384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of Positive End-Expiratory Pressure and Proning on Ventilation and Perfusion in COVID-19 Acute Respiratory Distress Syndrome.
    Perier F; Tuffet S; Maraffi T; Alcala G; Victor M; Haudebourg AF; De Prost N; Amato M; Carteaux G; Mekontso Dessap A
    Am J Respir Crit Care Med; 2020 Dec; 202(12):1713-1717. PubMed ID: 33075235
    [No Abstract]   [Full Text] [Related]  

  • 58. Positive End-Expiratory Pressure in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome: Higher May Be Too High.
    Tabone L; Martin S; Emeriaud G
    Crit Care Med; 2020 Dec; 48(12):1925-1927. PubMed ID: 33255120
    [No Abstract]   [Full Text] [Related]  

  • 59. Ambiguities.
    Möckel M
    Dtsch Arztebl Int; 2020 Oct; 117(42):717. PubMed ID: 33559589
    [No Abstract]   [Full Text] [Related]  

  • 60. Reader Response: Critical Illness-Associated Cerebral Microbleeds in COVID-19 Acute Respiratory Distress Syndrome.
    Edlow BL; Conklin J; Huang SY
    Neurology; 2021 Aug; 97(5):254. PubMed ID: 34341081
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.